Olena Morozova
Olena Morozova
Genome Sciences Centre, BC Cancer Agency
Verified email at bcgsc.ca
Cited by
Cited by
Applications of next-generation sequencing technologies in functional genomics
O Morozova, MA Marra
Genomics 92 (5), 255-264, 2008
The genetic landscape of high-risk neuroblastoma
TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ...
Nature genetics, 2013
Applications of new sequencing technologies for transcriptome analysis
O Morozova, M Hirst, MA Marra
Annual review of genomics and human genetics 10, 135-151, 2009
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
KR Taylor, A Mackay, N Truffaux, YS Butterfield, O Morozova, C Philippe, ...
Nature genetics 46 (5), 457-461, 2014
SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells
J Biernaskie, M Paris, O Morozova, BM Fagan, M Marra, L Pevny, ...
Cell stem cell 5 (6), 610-623, 2009
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
S Yip, YS Butterfield, O Morozova, S Chittaranjan, MD Blough, J An, I Birol, ...
The Journal of Pathology, 2012
Convergent Genesis of an Adult Neural Crest‐Like Dermal Stem Cell from Distinct Developmental Origins
H Jinno, O Morozova, KL Jones, JA Biernaskie, M Paris, R Hosokawa, ...
Stem Cells 28 (11), 2027-2040, 2010
LNCaP Atlas: Gene expression associated with in vivo progression to castration-recurrent prostate cancer
T Romanuik, G Wang, O Morozova, A Delaney, M Marra, M Sadar
BMC medical genomics 3 (1), 43, 2010
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth
B Das, R Antoon, R Tsuchida, S Lotfi, O Morozova, W Farhat, D Malkin, ...
Neoplasia (New York, NY) 10 (10), 1105, 2008
Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screens
KM Smith, A Datti, M Fujitani, N Grinshtein, L Zhang, O Morozova, ...
EMBO Molecular Medicine 2 (9), 371-384, 2010
Penetrance of biallelic SMARCAL1 mutations is associated with environmental and genetic disturbances of gene expression
A Baradaran-Heravi, KS Cho, B Tolhuis, M Sanyal, O Morozova, ...
Human molecular genetics 21 (11), 2572-2587, 2012
Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
D Chand, Y Yamazaki, K Ruuth, C Schönherr, T Martinsson, P Kogner, ...
Disease models & mechanisms 6 (2), 373-382, 2013
A Cancer Stem Cell Model for Studying Brain Metastases From Primary Lung Cancer
SM Nolte, C Venugopal, N McFarlane, O Morozova, RM Hallett, ...
Journal of the National Cancer Institute 105 (8), 551-562, 2013
From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors This paper is one of a selection of papers published …
O Morozova, MA Marra
Biochemistry and Cell Biology 86 (2), 81-91, 2008
System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma
O Morozova, M Vojvodic, N Grinshtein, LM Hansford, KM Blakely, ...
Clinical cancer research 16 (18), 4572-4582, 2010
Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance
MD O’Connor, E Wederell, G Robertson, A Delaney, O Morozova, ...
Experimental hematology 39 (8), 866-879. e1, 2011
DNA Hypermethylation and 1p Loss Silence NHE‐1 in Oligodendroglioma
MD Blough, M Al‐Najjar, C Chesnelong, CE Binding, AD Rogers, ...
Annals of Neurology, 2012
Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal
P Vrljicak, ACY Chang, O Morozova, ED Wederell, K Niessen, MA Marra, ...
Physiological genomics 40 (3), 150-157, 2010
A Seriation Approach for Visualization-Driven Discovery of Co-Expression Patterns in Serial Analysis of Gene Expression (SAGE) Data
O Morozova, V Morozov, BG Hoffman, CD Helgason, MA Marra
PloS one 3 (9), e3205, 2008
A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines.
M Vojvodic, LM Hansford, O Morozova, KM Blakely, P Taylor, KE Fathers, ...
Current drug discovery technologies, 2013
The system can't perform the operation now. Try again later.
Articles 1–20